![Margaret Lokash](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Margaret Lokash
Geen lopende functies
Profiel
Margaret Lokash worked as Vice President-Operations at Neos Therapeutics, Inc. She obtained an undergraduate degree and an MBA from the University of North Texas.
Eerdere bekende functies van Margaret Lokash
Bedrijven | Functie | Einde |
---|---|---|
NEOS THERAPEUTICS, INC. | Operationeel Directeur | - |
Opleiding van Margaret Lokash
University of North Texas | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Neos Therapeutics, Inc.
![]() Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |